A Randomised, Multi-Centre Study to Compare the Efficacy and Safety of Extended Release Quetiapine Fumarate (Seroquel XR TM) Tablets as Mono-Therapy or in Combination With Lithium in the Treatment of Patients With Acute Bipolar Depression.

Trial Profile

A Randomised, Multi-Centre Study to Compare the Efficacy and Safety of Extended Release Quetiapine Fumarate (Seroquel XR TM) Tablets as Mono-Therapy or in Combination With Lithium in the Treatment of Patients With Acute Bipolar Depression.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jul 2012

At a glance

  • Drugs Lithium; Quetiapine
  • Indications Bipolar I disorders; Bipolar II disorders
  • Focus Therapeutic Use
  • Acronyms QUALITY
  • Most Recent Events

    • 28 Jun 2012 Actual patient number changed from 488 to 421 according to ClinicalTrials.gov.
    • 10 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top